Questions? Call 800-624-6242
add to cart
Rights & Permissions
. "Appendix E: Workshop Agenda." Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease. Washington, DC: The National Academies Press, 2010.
Please select a format:
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Existing Frameworks for Biomarker Qualification—PhRMA—James Mayne
NIH Biomarker Qualification/Cancer Perspective—Arthur Schatzkin
Risk Factor to Surrogate Endpoint Pathway—Philip Greenland
Troponin—James de Lemos
CRP and Inflammatory Markers—Christie Ballantyne
Case Studies Discussion Speakers and Committee